
Validea's guru fundamental report rates Arthur J. Gallagher & Co. (AJG) at 56% using its Warren Buffett-inspired 'Patient Investor' model, falling short of the 80% threshold for typical interest. While the large-cap insurance firm demonstrates strengths in earnings predictability, return on assets, and free cash flow, it fails key criteria such as return on equity and expected return, suggesting it does not currently present a compelling long-term value opportunity under this specific investment strategy.
Arthur J. Gallagher & Co. (AJG) receives a mediocre 56% rating from Validea's 'Patient Investor' model, which is based on Warren Buffett's strategy and falls significantly short of the 80% threshold typically required to signal investment interest. The analysis reveals a company with a dual profile: on one hand, it demonstrates strong operational fundamentals, passing tests for earnings predictability, return on assets, free cash flow generation, and effective use of retained earnings. These factors point to a stable and predictable business. However, the company fails on critical criteria for value-oriented investors, specifically return on equity (ROE), initial rate of return, and expected future return. The neutral rating on share repurchases suggests its capital return policy is not a significant factor in the model's assessment. This mixed scorecard indicates that while AJG is a fundamentally sound large-cap insurance firm, its current valuation and profitability levels do not meet the stringent requirements of this particular long-term value strategy.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
0.00
Ticker Sentiment